Literature DB >> 22562850

Advances in glaucoma treatment and management: outflow drugs.

Paul L Kaufman1, Carol A Rasmussen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22562850      PMCID： PMC4898880          DOI： 10.1167/iovs.12-9483m

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN： 0146-0404            Impact factor:   4.799


× No keyword cloud information.
  31 in total

1.  Aqueous humor outflow: what do we know? Where will it lead us?

Authors:  Michael P Fautsch; Douglas H Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-10       Impact factor: 4.799

Review 2.  Enhancing trabecular outflow by disrupting the actin cytoskeleton, increasing uveoscleral outflow with prostaglandins, and understanding the pathophysiology of presbyopia interrogating Mother Nature: asking why, asking how, recognizing the signs, following the trail.

Authors:  Paul L Kaufman
Journal:  Exp Eye Res       Date:  2007-10-26       Impact factor: 3.467

3.  The effect of angiotensin II on uveoscleral outflow in rabbits.

Authors:  T Inoue; T Yokoyoma; H Koike
Journal:  Curr Eye Res       Date:  2001-08       Impact factor: 2.424

4.  Calculations of flow resistance in the juxtacanalicular meshwork.

Authors:  C R Ethier; R D Kamm; B A Palaszewski; M C Johnson; T M Richardson
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-12       Impact factor: 4.799

5.  Kappa opioid receptor localization and coupling to nitric oxide production in cells of the anterior chamber.

Authors:  Karen R Russell-Randall; Juanita Dortch-Carnes
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-13       Impact factor: 4.799

6.  Elevation of nitric oxide production in human trabecular meshwork by increased pressure.

Authors:  Andrea Schneemann; Ateunette Leusink-Muis; Thomas van den Berg; Philip F J Hoyng; Willem Kamphuis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-03-15       Impact factor: 3.117

7.  The role of the prostaglandin EP4 receptor in the regulation of human outflow facility.

Authors:  Lindsay H Millard; David F Woodward; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

8.  Cochlin expression in anterior segment organ culture models after TGFbeta2 treatment.

Authors:  Sanjoy K Bhattacharya; B'Ann T Gabelt; Jose Ruiz; Renata Picciani; Paul L Kaufman
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-03       Impact factor: 4.799

9.  Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma.

Authors:  Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill; Luciana M Alencar; Pamela A Sample; Cristiana Vasile; Christopher Bowd
Journal:  Ophthalmology       Date:  2007-10-15       Impact factor: 12.079

10.  Intraocular adenosine levels in normal and ocular-hypertensive patients.

Authors:  Bradley S Daines; Alexander R Kent; Melissa S McAleer; Craig E Crosson
Journal:  J Ocul Pharmacol Ther       Date:  2003-04       Impact factor: 2.671
View more
  21 in total

Review 1.  Deconstructing aqueous humor outflow - The last 50 years.

Authors:  Paul L Kaufman
Journal:  Exp Eye Res       Date:  2020-06-23       Impact factor: 3.467

Review 2.  Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.

Authors:  Rebecca K Donegan; Raquel L Lieberman
Journal:  J Med Chem       Date:  2015-09-25       Impact factor: 7.446

Review 3.  Exciting directions in glaucoma.

Authors:  Carol A Rasmussen; Paul L Kaufman
Journal:  Can J Ophthalmol       Date:  2014-12       Impact factor: 1.882

4.  Primary cilia signaling mediates intraocular pressure sensation.

Authors:  Na Luo; Michael D Conwell; Xingjuan Chen; Christine Insinna Kettenhofen; Christopher J Westlake; Louis B Cantor; Clark D Wells; Robert N Weinreb; Timothy W Corson; Dan F Spandau; Karen M Joos; Carlo Iomini; Alexander G Obukhov; Yang Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-20       Impact factor: 11.205

Review 5.  Ocular Purine Receptors as Drug Targets in the Eye.

Authors:  Kenneth A Jacobson; Mortimer M Civan
Journal:  J Ocul Pharmacol Ther       Date:  2016-08-30       Impact factor: 2.671

Review 6.  Glaucoma: recent advances in the involvement of autoimmunity.

Authors:  Maria Ida Rizzo; Antonio Greco; Armando De Virgilio; Andrea Gallo; Luciano Taverniti; Massimo Fusconi; Michela Conte; Giulio Pagliuca; Rosaria Turchetta; Marco de Vincentiis
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 7.  The trabecular meshwork in normal eyes and in exfoliation glaucoma.

Authors:  Carol A Rasmussen; Paul L Kaufman
Journal:  J Glaucoma       Date:  2014 Oct-Nov       Impact factor: 2.503

8.  Pulsatile motion of the trabecular meshwork in healthy human subjects quantified by phase-sensitive optical coherence tomography.

Authors:  Peng Li; Tueng T Shen; Murray Johnstone; Ruikang K Wang
Journal:  Biomed Opt Express       Date:  2013-09-06       Impact factor: 3.732

9.  Latrunculin B Reduces Intraocular Pressure in Human Ocular Hypertension and Primary Open-Angle Glaucoma.

Authors:  Carol A Rasmussen; Paul L Kaufman; Robert Ritch; Reza Haque; R Kim Brazzell; Jason L Vittitow
Journal:  Transl Vis Sci Technol       Date:  2014-09-03       Impact factor: 3.283

10.  Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells.

Authors:  Henry T Hsueh; Yoo-Chun Kim; Ian Pitha; Matthew D Shin; Cynthia A Berlinicke; Renee Ti Chou; Elizabeth Kimball; Julie Schaub; Sarah Quillen; Kirby T Leo; Hyounkoo Han; Amy Xiao; Youngwook Kim; Matthew Appell; Usha Rai; HyeYoung Kwon; Patricia Kolodziejski; Laolu Ogunnaike; Nicole M Anders; Avelina Hemingway; Joan L Jefferys; Abhijit A Date; Charles Eberhart; Thomas V Johnson; Harry A Quigley; Donald J Zack; Justin Hanes; Laura M Ensign
Journal:  Pharmaceutics       Date:  2021-05-01       Impact factor: 6.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.